Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm,open-label,phase 2 basket trial |
| |
| Affiliation: | 1. Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Málaga, Spain;2. MD Anderson Cancer Center, Houston, TX, USA;3. Gustave Roussy Cancer Campus, Villejuif, France;4. Paris Sud University, Orsay, France;5. START Madrid–Fundación Jiménez Díaz, Hospital Fundación Jiménez Díaz, Madrid, Spain;6. Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain;7. Organización Sanitaria Integrada Bilbao Basurto, Bilbao, Spain;8. University Hospital Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;9. Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense de Madrid, Madrid, Spain;10. Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain;11. Pharma Mar, Clinical Research and Development, Colmenar Viejo, Madrid, Spain;12. START Madrid–Centro Integral Oncológico Clara Campal, Hospital Universitario Sanchinarro, Madrid, Spain;13. Hôpital Cochin, Paris, France;14. Complejo Hospitalario de Navarra, Pamplona, Spain;15. Institut Claudius Regaud, Toulouse, France;p. Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium;q. University College London Cancer Institute, London, UK;r. Hospital Universitario Ramón y Cajal, Madrid, Spain;s. Ospedale San Giovanni, Bellinzona, Switzerland;t. Hospital Universitario Virgen de las Nieves, Granada, Spain;u. Hospital Universitario Reina Sofía, Cordoba, Spain;v. Hospital Universitario Miguel Servet, Zaragoza, Spain;w. Institute for Drug Development, Mays Cancer Center at University of Texas Health San Antonio, MD Anderson Cancer Center, San Antonio, TX, USA;x. Sarcoma Oncology Center, Santa Monica, CA, USA;y. Complexo Hospitalario Universitario A Coruña, A Coruña, Spain;z. Ospedale Santa Maria delle Croci, Ravenna, Italy;11. Humanitas Clinical and Research Center - IRCCS, Humanitas Cancer Center, Rozzano, Milan, Italy;12. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy;13. University of Colorado Cancer Center, Aurora, CO, USA;14. Dana-Farber Cancer Institute, Boston, MA, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
